What is Lakewood-Amedex Biotherapeutics Inc. Common Stock's Enterprise Value?

Lakewood-Amedex Biotherapeutics Inc. Common Stock's Enterprise Value is $5.2M, based on as-reported figures from SEC (XBRL) filings.

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Financial Statements

Lakewood-Amedex Biotherapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01ZK61CF1

XNAS · usd

2.18▲ 0.30 (15.96%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)—

EBITDA—

Diluted EPS (TTM)—

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.88

Day's Range1.89 – 2.27

52-Week Range0.37 – 9.82

Volume458.7K

Avg Volume316.1K

Share Statistics

Shares Outstanding

Employees—

ExchangeXNAS

Listed2026-04-23

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)

What is Lakewood-Amedex Biotherapeutics Inc. Common Stock's Market Cap?: Lakewood-Amedex Biotherapeutics Inc. Common Stock's Market Cap is $5.2M, based on as-reported figures from SEC (XBRL) filings.
What is Lakewood-Amedex Biotherapeutics Inc. Common Stock's Enterprise Value?: Lakewood-Amedex Biotherapeutics Inc. Common Stock's Enterprise Value is $5.2M, based on as-reported figures from SEC (XBRL) filings.
What is Lakewood-Amedex Biotherapeutics Inc. Common Stock's Net Debt?: Lakewood-Amedex Biotherapeutics Inc. Common Stock's Net Debt is -$11.7K, based on as-reported figures from SEC (XBRL) filings.